Product NDC: | 0832-1008 |
Proprietary Name: | Valproic Acid |
Non Proprietary Name: | valproic acid |
Active Ingredient(s): | 250 mg/1 & nbsp; valproic acid |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0832-1008 |
Labeler Name: | Upsher-Smith Laboratories, Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA073229 |
Marketing Category: | ANDA |
Start Marketing Date: | 19911029 |
Package NDC: | 0832-1008-00 |
Package Description: | 100 CAPSULE in 1 BOTTLE (0832-1008-00) |
NDC Code | 0832-1008-00 |
Proprietary Name | Valproic Acid |
Package Description | 100 CAPSULE in 1 BOTTLE (0832-1008-00) |
Product NDC | 0832-1008 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | valproic acid |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 19911029 |
Marketing Category Name | ANDA |
Labeler Name | Upsher-Smith Laboratories, Inc |
Substance Name | VALPROIC ACID |
Strength Number | 250 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC] |